33 / 38
33
6.
Batra RS, Kelley LC. A risk scale for predicting
extensive subclinical spread of nonmelanoma
skin cancer. Dermatol Surg 2002;28:107-12.
7.
Rowe DE, Carroll RJ, Day CL Jr. Mohs surgery
is the treatment of choice for recurrent
(previously treated) basal cell carcinoma. J
Dermatol Oncol Surg 1989;15:424-31.
8.
Mohs FE. Chemosurgery in cancer, gangrene
and infections. Springfield, ILL, Charles Thomas
publisher, 1956, p.112.
9.
Salache SJ, Amonette R. Morpheaform basal-cell
epitheliomas: study of subclinical extensions in
51 cases. J Dermatol Surg Oncol 1981;7:387-92
10.
Skaria M.
Recurrence of basosquamous carcinoma after Mohs micrographic surgery.Dermatology 2010;221:352-5.
11.
Hendrix JD, Parlette HL. Micronodular basal
cell carcinoma: a deceptive histologic subtype
with frequently clinically undected tumor
extension. Arch Dermatol 1996;132:295.
12.
Alonso T, Sánchez P, González A, Ingelmo J,
Ruiz I, Delgado S, et al. Mohs micrographic
surgery: our first 100 patients. Actas
Dermosifiliogr 2008;99:275-80.
13.
Su Sy, Giorlando F, Ek EW, Dieu T. Incomplete
excision of basal cell carcinoma: a prospective
trial. Plast Reconstr Surg 2007;120:1240-8.